Nipani, India

Rohan Pai

This inventor holds 1 USPTO granted patent and 1 EPO patent. Top assignees: Biocon Limited, Mylan Gmbh. Active years: 2021.


% Patents Active = 100.0

 

Average Co-Inventor Count = 2.0

ph-index = 1


Company Filing History:


Years Active: 2021

Loading Chart...
Loading Chart...
1 patent (USPTO):Explore Patents

Title: Rohan Pai: Innovator in Pharmaceutical Formulations

Introduction

Rohan Pai is a notable inventor based in Nipani, India. He has made significant contributions to the field of pharmaceutical formulations, particularly in the development of stable protein formulations.

Latest Patents

Rohan Pai holds a patent for a stable pharmaceutical formulation comprising a protein of interest, sorbitol, and polyethylene glycol (PEG). The formulation features a molar ratio of 550 to 700 moles of sorbitol to 1 mole of protein, with PEG to protein present in a molar ratio of 2-50:1. This innovative formulation is designed to be stable for at least four years at temperatures between 2-8°C when in lyophilized form. Additionally, the patent includes a process for preparing the composition and a pharmaceutical kit comprising the same.

Career Highlights

Throughout his career, Rohan Pai has worked with prominent companies in the pharmaceutical industry, including Biocon Limited and Mylan GmbH. His experience in these organizations has contributed to his expertise in developing innovative pharmaceutical solutions.

Collaborations

Rohan has collaborated with various professionals in his field, including his coworker, Kala Chandramouli. These collaborations have further enhanced his work and contributions to pharmaceutical innovations.

Conclusion

Rohan Pai is a distinguished inventor whose work in stable protein formulations has the potential to impact the pharmaceutical industry significantly. His innovative approach and dedication to research continue to pave the way for advancements in drug formulation.

Profile summary based on public USPTO records.
Please report any incorrect information to [email protected]
Loading…